Colleen Burns

Colleen Burns is an accomplished professional with a robust background in biometrics and statistics, currently serving as Executive Director of Biometrics at Travere Therapeutics since April 2018. Prior to this role, Colleen held the position of Senior Director of Development and Biometrics at Elcelyx Therapeutics Inc. from March 2013 to March 2018 and served as Senior Director of Biostatistics at Orexigen Therapeutics from January 2010 to March 2013. Colleen's experience also includes roles such as Associate Director of Statistics at Amylin Pharmaceuticals and Senior Research Scientist at ALZA Corporation. Colleen holds a PhD in Statistics from the University of California, Riverside, and a BS in Mathematics from California State University, Fullerton.